GOVERNMENT KEYNOTE SPEAKERS
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/gray_100.jpg)
Catherine (Katie) Gray, PharmD
Acting Director, Office of Prescription Drug Promotion, US Food and Drug Administration, Baltimore, MD
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/riordan_100.jpg)
Mary E. Riordan, JD
Senior Counsel to the Inspector General, HHS Inspector General, Washington, DC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/levantis_100.jpg)
Henry C. Levantis, JD
United States Attorney, US Attorney’s Office, Middle District of Tennessee, US Department of Justice, Nashville, TN
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/levy_100.jpg)
Joshua S. Levy, JD
Acting United States Attorney; Former Assistant United States Attorney, District of Massachusetts, US Department of Justice, Boston, MA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/romero_100.jpg)
Jacqueline C. Romero, JD
United States Attorney, US Attorney’s Office, Eastern District of Pennsylvania, US Department of Justice, Philadelphia, PA
KEYNOTE SPEAKERS
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/barzilay_100.jpg)
Regina Barzilay, PhD
School of Engineering Distinguished Professor for AI and Health, MIT Center for Machine Learning in Health; AI Faculty Lead, Jameel Clinic, MIT Computer Science & Artificial Intelligence Lab; Recipient, MacArthur Genius Fellowship, NSF Career Award, and AAAI Squirrel AI Award for Artificial Intelligence for the Benefit of Humanity, Cambridge, MA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/dentzer_100.jpg)
Susan Dentzer, MS
President and Chief Executive Officer, America’s Physician Groups; Wrote and Hosted PBS documentary, Reinventing American Healthcare; Former Editor in Chief, Health Affairs; Former Health Correspondent, PBS NewsHour, Washington, DC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/potter_100.jpg)
Myrtle Potter
Board, Liberty Mutual, Guardant Health, Opentrons & Univ of Chicago; Former President and CEO, Sumitomo Pharma America & Chair, Sumitomo Pharma UK; Former CEO, Sumitovant Biopharma; Former Vant Operating Chair, Roivant; Former President, Commercial Operations, Genentech; Former President, Cardiovascular/Metabolics, BMS, Cambridge, MA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/saunders_100.jpg)
Brent Saunders, MBA, JD
Chairman & Chief Executive Officer, Bausch + Lomb; Former Chair, President & CEO, Allergan; President & CEO, Actavis plc; President & CEO, Forest Laboratories; President, Global Consumer Healthcare; Schering-Plough; Co-founder, International Association of Privacy Professionals (IAPP) and Pharmaceutical Compliance Forum (PCF), Miami Beach, FL
ANNUAL UPDATES FROM ADVAMeD, PhRMA AND BIO
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/delacourt_100.jpg)
John Delacourt, JD
Deputy General Counsel, Biotechnology Innovation Organization; Former Chief Antitrust Counsel, Office of Policy Planning, Federal Trade Commission, Washington, DC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/nassar_100.jpg)
Ida Nassar, JD
Vice President, Assistant General Counsel, Ethics & Compliance, AdvaMed; Former Senior Attorney, Office of Chief Counsel, Drug Enforcement Administration, Washington, DC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/wagner_100.jpg)
Julie Ritchie Wagner, JD
Senior Assistant General Counsel, PhRMA; Former Senior Counsel, Office of Counsel to the Inspector General, US Department of Health and Human Services, Washington, DC
FEATURED FACULTY
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/amendola_100.jpg)
David Amendola
Director, Resolution Economics; Former, Global Compliance Risk Evaluation and Management, ConvaTec, New York, NY
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/arnold_100.jpg)
Deidre Arnold, JD
Vice President TR Strategy/US TTR Franchise, Commercial Legal, Alnylam Pharmaceuticals, Cambridge, MA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/badlan_100.jpg)
Samantha Barrett Badlan, JD
Partner, Litigation & Enforcement Group, Ropes & Gray, Washington, DC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/bahl_100.jpg)
Yogesh Bahl, MBA
Partner & Leader, Life Sciences & Healthcare Practice, Resolution Economics; CFO & Head Investor Relations, IACTA Pharma, New York, NY
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/baim_100.jpg)
Eric M. Baim
Partner Dovetail; Former VP, Head of Compliance, US, Shire; Former Executive Director, Global Integrity & Compliance, Novartis, Boston, MA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/balasubramanian_100.jpg)
Shuba Balasubramanian, MBA
Principal, Deloitte, Dallas, TX
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/berger_100.jpg)
David Berger, JD
Senior Managing Director and Life Sciences Practice Lead, Ankura, New York, NY
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/bohnenkamp_100.jpg)
Brian A. Bohnenkamp, MHA, JD
Partner, FDA & Life Sciences Practice, King & Spalding, Washington, DC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/bolesh_100.jpg)
Eric Bolesh
Chief Operating Officer, Cutting Edge Information, Durham, NC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/bonistalli_100.jpg)
Ryan Bonistalli, JD
Senior Director, Compliance, Ultragenyx; Former Director, Corporate Compliance, Kaleo, San Francisco, CA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/bragg_100.jpg)
Jennifer Bragg, JD
Partner, Latham & Watkins; Former Associate Chief Counsel for Enforcement, Office of Chief Counsel, US FDA, Washington, DC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/broestl_100.jpg)
Noah Broestl, MS
Partner & Associate Director of Responsible AI, Boston Consulting Group (BCG); Former Safety Evaluations, Lead TPM, Bard, Google, Brooklyn, NY
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/brunetti_100.jpg)
Alfred R. Brunetti, JD
Principal, Porzio, Bromberg & Newman; Former Assistant Prosecutor, Union County Prosecutor’s Office, Morristown, NJ
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/burra_100.jpg)
Sri Burra, MBA
Former Ethics & Compliance Lead, North America, Haleon; Former Transformation Lead, Ethics & Compliance Workstream, GSK, Malvern, PA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/chanda_100.jpg)
Parth Chanda, MPA, JD
Founder & CEO, Lextegrity; Former Chief Compliance Counsel – Global Oncology, Pfizer, New York, NY
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/clark_100.jpg)
Andrew Clark, MBA
Partner/Principal, Forensic & Integrity Services, EY, Washington, DC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/clark_yvonne_100.jpg)
Yvonne Clark, JD
Vice President, Head of Corporate Compliance, Spark Therapeutics; Former Commercial Counsel, Merck, Philadelphia, PA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/cobourn_100.jpg)
Chris Cobourn, MS
Managing Director GP Practice Lead, HELIO, Placida, FL
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/colon_100.jpg)
Jessica Colón, JD, MPH, CHC
Vice President, Associate General Counsel, Chief Compliance & Privacy Officer, West Business Compliance & Integrity, West Pharmaceutical Services, Inc., Exton, PA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/cone_100.jpg)
Patricia Cone, PhD
Director, Compliance (R&D, Medical Affairs), Boehringer Ingelheim; Former Head, Global R&D Compliance, Takeda, Ridgefield, CN
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/davella_100.jpg)
BJ D’Avella, MBA
Group Leader, Life Sciences Consulting Group, Paul Hastings, New York, NY
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/datta_100.jpg)
Meenakshi Datta, JD
Partner and Global Co-leader, Healthcare Practice, Sidley Austin, Chicago, IL
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/davar_100.jpg)
Mahnu V. Davar, MA, JD
Partner and Co-chair, Life Sciences & Healthcare Regulatory, Arnold & Porter, Washington, DC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/davies_100.jpg)
Adriana Davies, JSM
VP, Compliance & Data Privacy, Smith & Nephew; Former Senior Compliance Director MITG, Medtronic, Jacksonville, FL
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/dawson_100.jpg)
James M. Dawson
VP, Compliance Solutions, Qordata; Former VP & CCO, United Therapeutics; Former VP, Global Compliance Officer, Consumer Healthcare, GSK, Carrboro, NC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/deehr_100.jpg)
Manya Deehr, JD
Founder and Principal, Deehr Law LLC, Newtown, PA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/deguarde_100.jpg)
Audrey DeGuarde, MSJ
Vice President, Customer Success & Compliance Operations, RLDatix Life Sciences, Morristown, NJ
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/delvecchio_100.jpg)
Gary Del Vecchio
Health Care Compliance Officer Global Medical Affairs, Data Sciences, Cardiopulmonary & Business Development, Johnson & Johnson, Titusville, NJ
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/demske_100.jpg)
Gregory Demske, JD
Partner, Goodwin Procter; Former Chief Counsel, HHS Office of Inspector General, Washington, DC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/difrancesca_100.jpg)
Sarah diFrancesca, JD
Executive Director Compliance, Dermatology, Incyte, Chadds Ford, PA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/dilanno_100.jpg)
Donald DiLanno, MBA
Director of Global Healthcare Compliance, Insmed; Former Senior Manager, Compliance, Mallinckrodt, Lebanon, NJ
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/doebler_100.jpg)
Stefanie A. Doebler, JD
Partner and Co-Chair, Health Care Practice Group, Covington & Burling, LLP, Washington, DC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/dowdle_100.jpg)
S. Joy Dowdle, JD
Partner, Paul Hastings, Houston, TX
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/dunn_100.jpg)
Avia M. Dunn, JD, MBA
Partner, Life Sciences and Health Care, Skadden, Arps, Slate, Meagher & Flom, Washington, DC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/ebel_100.jpg)
Kip Ebel, MBA
Principal, Fraud Investigation & Dispute Services, EY, New York, NY
![](https://www.pharmacongress.com/wp-content/themes/ipc/faculty/elberg_100.jpg)
Jacob T. Elberg, JD
Associate Professor & Director, Center for Pharma Law, Seton Hall School of Law; Former AUSA, US Attorney’s Office, District of New Jersey, Newark, NJ
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/ercoli_100.jpg)
Aurelie Ercoli, LLM, PhD
Partner, White-Collar, Investigations and Government Enforcement Practice Group, DLA Piper, Washington, DC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/falcione_100.jpg)
Andrea Falcione, JD, CCEP
Chief Ethics & Compliance Officer & Head of Advisory Services, Rethink Compliance, Boston, MA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/falcone_100.jpg)
David Falcone, MS
Vice President Global Compliance, Merz Aesthetics; Former Director of Privacy, Ethics and University Compliance Officer, Duke University, Raleigh, NC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/feltz_100.jpg)
Margaret K. Feltz, MA, JD
Vice President, Ethics & Compliance, CCO, Purdue Pharma LP; Former Co-chair, PCF, Stamford, CT
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/fisher_100.jpg)
David Fisher, MS
President & Chief Operating Officer, TD International, Washington, DC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/florence_100.jpg)
Maya P. Florence, JD
Partner, Life Sciences and Health Care, Skadden, Arps, Slate, Meager & Flom, Boston, MA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/frank_100.jpg)
Sara K. Frank, JD
Principal, Choate Hall & Stewart, Boston, MA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/franklin_100.jpg)
Sarah A. Franklin, JD
Partner and Vice-Chair, Life Sciences Investigations Practice, Covington & Burling, LLP; Former Attorney, US Federal Trade Commission, Washington, DC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/gadlock_100.jpg)
Paul S. Gadiock, JD
Partner, McDermott Will & Emery; Former Associate Center Director for Policy, FDA Center for Devices and Radiological Health and, San Franciso, CA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/gandhi_100.jpg)
Abhiroop Gandhi, MBA, MS
Vice President, Compliance, Rigel Pharmaceuticals; Former Trust & Compliance Officer & Head, Strategic Risk Management, Verily (Google Life Sciences), San Francisco, CA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/garcia_n_100.jpg)
Nereyda Garcia, JD
Head, Ethics & Compliance, US Business Unit, Takeda; Former Compliance Head, Rare Disease & Rare Blood Disorders, Sanofi, Boston, MA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/giampetruzzi_100.jpg)
Gary F. Giampetruzzi, JD
Partner & Global Chair Life Sciences Department, Paul Hastings; Former VP, Assistant General Counsel, Pfizer, New York, NY
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/gobena_100.jpg)
Gejaa T. Gobena, JD
Partner, Hogan Lovells; Former Deputy Chief, Fraud Section, Criminal Division, US Department of Justice, Washington, DC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/gordon_100.jpg)
Christine Gordon, JD
CCO & Head of GRC; Governance, Risk & Compliance Function, Olympus; Former Assistant DA, Philadelphia DA’s Office, Bethlehem, PA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/grant_100.jpg)
Audriana “Audi” Grant
Senior Manager, Monitoring & Auditing, Ethics, Compliance & Privacy, Plainsboro, NJ
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/grygiel_100.jpg)
Nancy Grygiel, LLM
Senior Vice President and Chief Compliance Officer, Amgen; Former VP Compliance, Corporate and International, Allergan, Newbury Park, CA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/guerrero_100.jpg)
Jaime Guerrero, JD
Vice President, Global Compliance, Edwards Lifesciences; Former AUSA, United States Attorneys’ Office, Central District of California, Irvine, CA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/gupta_100.jpg)
Neeraj Gupta, MBA
President & Chief Technology Officer, Cresen Solutions, Chester Springs, PA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/hall_k_100.jpg)
Kris Hall, JD, CIPP/CIPM
Managing Director, Dovetail Consulting Group; Former VP, Chief Privacy Officer, Celgene, Bridgton, ME
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/harrold_100.jpg)
Kassie Harrold, JD
Executive Vice President, Chief Compliance Officer, Integrity & Compliance, Mallinckrodt; Former Global Compliance Counsel, Solutia, Hampton, NJ
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/heft_100.jpg)
Nevada Heft, JD
Global Privacy Director, Merck, Upper Gwyneed, PA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/helman_100.jpg)
Saul B. Helman, MD, MBA
President, Epsilon Life Sciences, Chicago, IL
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/hercz_100.jpg)
Michael G. Hercz, JD
Senior VP & General Counsel, Sentyn; Former Executive Director, Enterprise Risk Management, Amgen, Los Angeles, CA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/heyduk_100.jpg)
Laura Heyduk
Head, US Compliance, Biogen; Former Compliance Director, Healthcare Compliance, Insulet, Newtonville, MA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/holloway_100.jpg)
Howard Holloway
Global Governance Lead, Global Medical Affairs & Governance, Patient Oriented Programs, Novartis, Zurich, Switzerland
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/horton_100.jpg)
Casey Horton
Managing Director, Epsilon Life Sciences; Former Director, Compliance Operations, AbbVie, Chicago, IL
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/johnston_100.jpg)
Amanda Johnston, JD, RAC
Managing Attorney, Gardner Law, PLLC; Adjunct Professor of Law, Mitchell Hamline School of Law, St. Paul, MN
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/jones_100.jpg)
Erin Brown Jones, MA, JD
Partner, Latham & Watkins, Washington, DC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/kaschak_100.jpg)
Melissa Kaschak, CPA, CFE, CISA
Compliance Operations, Olympus; Former Information Protection Officer, Penn Mutual, Allentown, PA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/kassaby_100.jpg)
Rim El Kassaby, LLM
Director US Business Counseling & Support, Organon, Dubai, UAE